Erratum: BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non–Small Cell Lung Cancer

Journal of Clinical Oncology 2026 Open access

Read full text

Authors: Jordi Remón, Tina Cascone, Solange Peters

DOI: 10.1200/jco-26-00221

Cited by: 0

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations